Research in horses may eventually lead to a treatment for people who develop blindness as a result of the autoimmune disease ...

The eyedrops Larkin and his team developed contain a synthetic peptide that acts to block the pathways which cause the ...

Picture a horse running across an open field, the wind blowing his mane, his hooves stamping into the grassy knoll, eyes on ...

Median age at onset for anterior uveitis was 9.9 years (range 1.7–17.7), intermediate 9.4 years (6.8–16.3), posterior 11.1 years (range 7.3–16.1) and panuveitis 11.3 years (range 4.3–16.0) (figure 3).

Acelyrin has punted the autoimmune drug prospect izokibep back ... which it scored a phase 2b/3 win earlier in 2024—to leave uveitis as its last remaining area of active izokibep development.

Autoimmune disorders occur when immune cells go wrong and attack the body’s own tissues. Currently, autoimmune disorders are largely treated by broad immunosuppressive agents and blocking antibodies, ...

These findings enhance our understanding of the mechanisms behind anterior uveitis and its connection to common autoimmune diseases.These findings contribute to a better understanding of the ...

Immune recovery uveitis is an ocular complication related to management of HIV infection with HAART and has become an important cause of vision loss.

These findings contribute to a better understanding of the mechanisms behind anterior uveitis and its connection to common autoimmune diseases. Each year, approximately 600 Finns are diagnosed ...

These findings contribute to a better understanding of the mechanisms behind anterior uveitis and its connection to common autoimmune diseases. Each year, approximately 600 Finns are diagnosed ...

The in-silico results indicate the vaccine’s potential efficacy in activating immune responses. Future experimental validation and clinical studies are necessary to confirm the safety and efficacy of ...